Meet the future of ATMP commercialisation at Europe’s premier partnering event at Phacilitate’s 3rd Cell & Gene Therapy Europe. Join 400 industry decision-makers and key external stakeholders at the event which defines the strategic roadmap to European success for cell & gene therapy developers, ensuring European patients gain access to the game-changing biotherapeutics of tomorrow.
Be a part of the only European event that offers extensive coverage of ATMP R&D, manufacturing and regulatory issues and challenges, translating innovation to global success.
For further information click here.
This content is blocked. Accept cookies to view the content.